Provider
Ctexli - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026
Documents & Forms Results
Displaying 3661 - 3670 of 3754 results
Provider
Leucovorin - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026
Provider
Weight Management GLP-1 - Commercial
Coverage Exception, Formulary Exception
Program effective Date: Sep 01, 2026
Provider
Interleukin-13 (IL-13) Antagonist - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026
Provider
Vascepa - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026
Provider
Interleukin-5 (IL-5) Inhibitors - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026
Provider
Interleukin-4 (IL-4) Inhibitors - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026
Provider
Proton Pump Inhibitors (PPIs) - Commercial
Step Therapy, Quantity Limit
Program effective Date: Sep 01, 2026
Provider
Xolair (omalizumab) - Commercial
Prior Authorization
Program effective Date: Sep 01, 2026
Provider
Neurotrophic Keratitis - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026